The EU's generic drug market is shaped by four approval pathways, each with different timelines and costs. The 2025 Pharma Package reforms are accelerating market entry, but national inconsistencies still delay access for patients across Europe.
Read More
Microscopic Colitis: How Budesonide Treats Chronic Diarrhea
How to Work With Your Doctor to Deprescribe and Save Money on Prescriptions
Ampicillin: History, Development, and Impact on Modern Medicine
Opioids During Pregnancy: Risks, Withdrawal, and Monitoring
Natural Ways to Lower Cholesterol vs Statins: Diet, Exercise & Alternatives
